Meyka Pro banner
CurveBeam AI Limited

CurveBeam AI Limited (CVB.AX) Stock Overview

Explore CurveBeam AI Limited’s financial performance, market position, analyst ratings, and future outlook.

CVB.AX●ASX
HealthcareMedical - Devices
$0.02
$0.001(6.25%)
Australian Market opens in 53h 3m

CurveBeam AI Limited (CVB.AX)

Meyka AI Score

Z

Key Financials

Market Cap13M
P/E RatioN/A
EPS (TTM)$-0.04
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Month$0.01
3 Months$0.00
1 Year Target$0.00

CVB.AX Stock Analysis & Investment Overview (ASX)

Our AI-powered analysis of CurveBeam AI Limited (ASX: CVB.AX) gives investors deep insight into how the stock performs on the ASX exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, CurveBeam AI Limited's ASX-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CVB.AX on the ASX shows an RSI of 33.28, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the ASX listing.

Key metrics behind CurveBeam AI Limited's ASX-traded stock include a P/E ratio of N/A and a market capitalization of 13M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CVB.AX on the ASX.

Price Performance (ASX: CVB.AX)

1-Day Change
N/A
5-Day Change
-16.67%
1-Month Change
-37.50%
3-Month Change
-16.67%
6-Month Change
-72.73%
Year-to-Date (YTD) Change
-79.73%
1-Year Change
-81.25%
3-Year Change
-95.71%
5-Year Change
-95.59%
All-Time (Max) Change
-95.59%

Contact Information

NaN
2800 Bronze Drive, Hatfield, PA, 19440

Company Facts

IPO DateAug 23, 2023
CountryUS
Actively Trading

Frequently Asked Questions